Literature DB >> 16695537

STUDIES OF HEMOPHILIA. II. THE ASSAY OF THE ANTIHEMOPHILIC CLOT-PROMOTING PRINCIPLE IN NORMAL HUMAN PLASMA WITH SOME OBSERVATIONS ON THE RELATIVE POTENCY OF CERTAIN PLASMA FRACTIONS.

B Alexander1, G Landwehr.   

Abstract

Entities:  

Year:  1948        PMID： 16695537      PMCID： PMC439478          DOI： 10.1172/JCI101929

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  9 in total

1.  THE COAGULATION DEFECT IN HEMOPHILIA: THE EFFECT, IN HEMOPHILIA, OF THE PARENTERAL ADMINISTRATION OF A FRACTION OF THE PLASMA GLOBULINS RICH IN FIBRINOGEN.

Authors:  G R Minot; C S Davidson; J H Lewis; H J Tagnon; F H Taylor
Journal:  J Clin Invest       Date:  1945-09       Impact factor: 14.808

2.  STUDIES IN BLOOD COAGULATION: THE COAGULATION PROPERTIES OF CERTAIN GLOBULIN FRACTIONS OF NORMAL HUMAN PLASMA IN VITRO.

Authors:  F H Taylor; C S Davidson; H J Tagnon; M A Adams; A H Macdonald; G R Minot
Journal:  J Clin Invest       Date:  1945-09       Impact factor: 14.808

3.  HEMOPHILIA. II. SOME PROPERTIES OF A SUBSTANCE OBTAINED FROM NORMAL HUMAN PLASMA EFFECTIVE IN ACCELERATING THE COAGULATION OF HEMOPHILIC BLOOD.

Authors:  A J Patek; F H Taylor
Journal:  J Clin Invest       Date:  1937-01       Impact factor: 14.808

4.  CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. I. THE CHARACTERIZATION OF THE PROTEIN FRACTIONS OF HUMAN PLASMA.

Authors:  E J Cohn; J L Oncley; L E Strong; W L Hughes; S H Armstrong
Journal:  J Clin Invest       Date:  1944-07       Impact factor: 14.808

5.  CHEMICAL, CLINICAL AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION: XXXII. THE COAGULATION DEFECT IN HEMOPHILIA. AN IN VITRO AND IN VIVO COMPARISON OF NORMAL AND HEMOPHILIC WHOLE BLOOD, PLASMA AND DERIVED PLASMA PROTEIN FRACTIONS.

Authors:  J H Lewis; C S Davidson; G R Minot; J P Soulier; H J Tagnon; F H Taylor
Journal:  J Clin Invest       Date:  1946-11       Impact factor: 14.808

6.  HEMOPHILIA. I. THE ABNORMAL COAGULATION OF THE BLOOD AND ITS RELATION TO THE BLOOD PLATELETS.

Authors:  A J Patek; R P Stetson
Journal:  J Clin Invest       Date:  1936-09       Impact factor: 14.808

7.  THE COAGULATION DEFECT IN HEMOPHILIA: STUDIES OF THE CLOT PROMOTING ACTIVITY ASSOCIATED WITH PLASMA EUGLOBULIN IN HEMOPHILIA.

Authors:  E L Lozner; F H Taylor
Journal:  J Clin Invest       Date:  1939-11       Impact factor: 14.808

8.  CHEMICAL, CLINICAL AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. XXXIII. THE COAGULATION DEFECT IN HEMOPHILIA: THE EFFECT IN VITRO AND IN VIVO ON THE COAGULATION TIME IN HEMOPHILIA OF A PROTHROMBIN AND FIBRINOGEN-FREE NORMAL PLASMA AND ITS DERIVED PROTEIN FRACTIONS.

Authors:  J H Lewis; J P Soulier; F H Taylor
Journal:  J Clin Invest       Date:  1946-11       Impact factor: 14.808

9.  THE COAGULATION DEFECT IN HEMOPHILIA. THE EFFECT IN HEMOPHILIA OF INTRAMUSCULAR ADMINISTRATION. OF A GLOBULIN SUBSTANCE DERIVED FROM NORMAL HUMAN PLASMA.

Authors:  F J Pohle; F H Taylor
Journal:  J Clin Invest       Date:  1937-09       Impact factor: 14.808
  9 in total
  4 in total

1.  Haemophilia and haemophilic arthropathy. An historical review and a clinical study of 42 cases.

Authors:  J B WEBB; A S DIXON
Journal:  Ann Rheum Dis       Date:  1960-06       Impact factor: 19.103

2.  Physiopathological classification of the haemorrhagic diseases.

Authors:  P DE NICOLA
Journal:  Can Med Assoc J       Date:  1952-12       Impact factor: 8.262

3.  Effect of platelet extract on hemophilic blood.

Authors:  E MOND; K SINGER
Journal:  J Clin Invest       Date:  1951-01       Impact factor: 14.808

4.  Selective human factor VIII activity measurement after analytical in-line purification.

Authors:  Andrea Engelmaier; Gerald Schrenk; Manfred Billwein; Herbert Gritsch; Christoph Zlabinger; Alfred Weber
Journal:  Res Pract Thromb Haemost       Date:  2022-10-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.